type here...

CATEGORIES

Discover Drugs

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Why We Should Be Cautious With COVID-19 Medical Research

Dr Jeff Livingston -
Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

Dr Jeff Livingston -
She is sick of using birth control, but now is not the right time to get pregnant. The “pull and pray” method is too...

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories